Massanu Sirleaf
Acute Care · El Cajon, CANPI 1962725382
Payments from drug & device makers
Across 154 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$769
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$356
- AbbVie$312
- Novo Nordisk$308
- Bayer$254
- Neurelis, Inc.$194
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,493100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 43 | $769 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $356 |
| AbbVie | 15 | $312 |
| Novo Nordisk | 10 | $308 |
| Bayer | 8 | $254 |
| Neurelis, Inc. | 9 | $194 |
| Otsuka America Pharmaceutical, Inc. | 7 | $179 |
| AstraZeneca | 3 | $157 |
| Novartis | 9 | $142 |
| Lundbeck LLC | 4 | $117 |
| GSK | 5 | $90 |
| Amgen | 4 | $84 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $62 |
| Boston Scientific | 2 | $61 |
| Sanofi-aventis U.S. LLC | 2 | $47 |
| Exact Sciences | 2 | $41 |
| Johnson & Johnson | 1 | $37 |
| Pulmonx Corporation | 1 | $31 |
| Tempus AI, Inc | 1 | $29 |
| Microtransponder, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Merck | 1 | $24 |
| Grifols USA, LLC | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Abiomed | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Nevro Corp. | 1 | $18 |
| Lucid Diagnostics Inc. | 1 | $15 |
| VBI Vaccine (delaware) Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,493 in reported general payments places this provider in the 90th percentile of 1,153 acute care providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 22 | $32,731 |
| OzempicSemaglutide | 18 | $28,993 |
| FarxigaDapagliflozin Propanediol | 14 | $15,973 |
| EliquisApixaban | 21 | $15,368 |
| TrulicityDulaglutide | 11 | $13,768 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $11,145 |
| Pentazocine-Naloxone HclPentazocine Hcl/Naloxone Hcl | 12 | $3,784 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 15 | $990 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $932 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $910 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $866 |
| Atorvastatin Calcium | 96 | $773 |
| Levothyroxine Sodium | 43 | $704 |
| Tramadol Hcl | 59 | $517 |
| Losartan Potassium | 67 | $473 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $308 | $61,72540 claims |
| AstraZenecaFarxiga | $157 | $15,97314 claims |
| Lilly USA, LLCTrulicity | $769 | $13,76811 claims |
| GSKTrelegy Ellipta | $90 | $11,14514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,153 acute care providers in California.
Other acute care in El Cajon
- Leslie PetersenCamarillo$370K
- Joyce KhremianSan Dimas$73K
- Eleanor VierraSacramento$64K
- Frances DyLos Angeles$57K
- Savannah HarrisVentura$56K
- Kori Ann JohnstonLos Angeles$42K
- Caroline KwongOrange$42K
- Gregory KnutzenColton$41K
- Sunita BoparaiLos Angeles$37K
- Sherona BauLos Angeles$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.